Pesce A. Why pharmacogenetic testing should be reimbursed by Medicare and commercial health insurance. J of Opioid Management [Internet]. 2024 Aug. 1 [cited 2024 Nov. 24];20(4):267. Available from: https://wmpllc.org/ojs/index.php/jom/article/view/3677